Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Noema Pharma AG is a Swiss-based clinical-stage biopharmaceutical company dedicated to developing and commercializing therapies for orphan and other rare neurological disorders of the central nervous system (CNS). Their pipeline targets conditions with high unmet medical needs, leveraging a patient-centric approach to drug development. Key areas of focus include treatments for conditions like Trigeminal Neuralgia, seizures in Tuberous Sclerosis Complex, and Rett Syndrome. The company aims to translate novel scientific discoveries into meaningful treatments for patients.
Serves as the central hub for Noema Pharma's corporate governance, strategic planning, research and development oversight, clinical trial management, and business development activities.
Located within the Switzerland Innovation Park Basel Area (site Allschwil), a key life sciences hub, fostering collaboration and access to cutting-edge research facilities and talent.
A dynamic, science-driven, and collaborative work environment focused on innovation in CNS therapies. The culture emphasizes patient-centricity, agility in research and development, and a commitment to scientific excellence.
The headquarters in the Basel area is strategically important for its proximity to world-class research institutions, a skilled talent pool, and a strong network of pharmaceutical and biotech companies, crucial for a clinical-stage company.
While headquartered in Switzerland, Noema Pharma AG maintains a global operational footprint, primarily through its clinical trial activities conducted across multiple countries in North America and Europe. The company collaborates with international research institutions, contract research organizations (CROs), and healthcare professionals to advance its pipeline of CNS therapies for patients worldwide. Its investor base is also international, underscoring global confidence in its scientific and commercial strategy.
Hegenheimermattweg 167A
Allschwil
Basel-Landschaft
Switzerland
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Noema Pharma' leadership includes:
Noema Pharma has been backed by several prominent investors over the years, including:
Noema Pharma has strengthened its leadership team over the past year with key appointments in people operations and legal/compliance, supporting its growth and the advancement of its clinical pipeline.
Discover the tools Noema Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Noema Pharma AG likely utilizes common corporate email formats. While specific internal patterns can vary, standard formats often include combinations of first name, last name, and initials with the @noemapharma.com domain. The most probable format is [first_name].[last_name]@noemapharma.com.
[first_name].[last_name]@noemapharma.com
Format
jane.doe@noemapharma.com
Example
85%
Success rate
Business Wire • January 8, 2024
Noema Pharma announced the enrollment of the first patient in its Phase 2b LibraTN clinical trial. The study will evaluate the efficacy and safety of basimglurant (NOE-101), an mGluR5 inhibitor, for the treatment of pain associated with Trigeminal Neuralgia (TN)....more
PR Newswire • September 7, 2023
Noema Pharma successfully completed a Series B financing round, raising CHF 103 million (USD 112 million). The funds will advance its clinical pipeline, including basimglurant (NOE-101) for Trigeminal Neuralgia, gemlapodect (NOE-105) for Tuberous Sclerosis Complex, and NOE-115 for Rett Syndrome....more
PR Newswire • August 22, 2023
Noema Pharma announced the appointment of Catherine Jewell, PhD, as Chief People Officer. Dr. Jewell brings extensive experience in human resources and organizational development within the life sciences sector and will lead Noema's people strategy to support its growth....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Noema Pharma, are just a search away.